Heidelberg launches OCT2, Heyex PACS

Article

Heidelberg Engineering GmbH recently launched two new products, OCT2, the next generation OCT module for Spectralis diagnostic imaging, and the Heyex picture archiving and communication system (PACS).

Heidelberg, Germany-Heidelberg Engineering GmbH recently launched two new products, OCT2, the next generation OCT module for Spectralis diagnostic imaging, and the Heyex picture archiving and communication system (PACS).

According to the company, the OCT2 module combines a 70 kHz A-scan rate with Heidelberg Engineering’s TruTrack high-speed active eye tracking.

Anterior segment imaging may have saved a life

The OCT2 module is now available as an option for all models of the Spectralis product family. In addition, all Advanced Systems, those purchased with the Advanced Upgrade Package or with the MultiColor module, can be upgraded to the OCT2 module.

The Heyex PACS software platform will support Heidelberg Engineering devices and can also integrate imaging devices of other manufacturers and diagnostic data into a centralized database. Heidelberg says this will allow eyecare practitioners to access, review, and compare all clinical images in one central application. The platform evolves from the Heyex (Heidelberg Eye Explorer) image management, networking, and device control software incorporated in every Heidelberg Engineering instrument. 

Newsletter

Want more insights like this? Subscribe to Optometry Times and get clinical pearls and practice tips delivered straight to your inbox.

Recent Videos
Rachelle Lin, OD, MS, FAAO, on collaborating more effectively on neovascular retinal cases
Susana Marcos, PhD, discusses the implications her research presents for the role optical coherence tomography (OCT) could play in presbyopia and myopia accommodation efforts.
Susana Marcos, PhD, outlines a presentation she gave at ARVO 2025 on a unique utilization of optical coherence tomography.
Dr Luke Lindsell discusses retinal therapy and geographic atrophy at Controversies in Modern Eye Care 2025
Paul Hammond, OD, FAAO, presents a poster at ARVO 2025 on the creation of a conversion factor between 2 OCT devices to monitor glaucoma progression
CIME 25: Dilsher Dhoot, MD, FASRS, is excited about emerging retinal therapies.
Steven Ferrucci, OD, FAAO, at Controversies in Modern Eyecare 2025
CRU 2025 provided the latest insights regarding glaucoma, dry eye disease, retina, myopia, neurotrophic keratitis, and keratoconus.
Rachelle Lin, OD, MS, FAAO
Rachelle Lin, OD, MS, FAAO, at CRU Eye Symposium 2025
© 2025 MJH Life Sciences

All rights reserved.